31308051457?profile=RESIZE_710x

Plenty of good products get stuck at the same point: regulatory approval. The device is ready, the buyers are waiting, and then someone asks, “Do we have the CDSCO licence?” Suddenly the launch date is in doubt.

At UMSPCS, we help manufacturers, importers, and start-ups work through this process. This guide covers what the approval involves, which licence applies to you, and the mistakes that cost businesses the most time.

What Is CDSCO and Why Does It Matter?

The Central Drugs Standard Control Organisation (CDSCO) is India’s national regulator for drugs, medical devices, and cosmetics. If you make, import, or sell regulated products in India, you generally need its CDSCO approval licence from the relevant authority.

Operating without the right licence risks rejected shipments, blocked tenders, penalties, and lost trust with hospitals and distributors. Getting it right early is far cheaper than fixing it later.

Know Your Device Class First

For medical devices, everything starts with risk classification, from Class A (low risk) to Class D (high risk). CDSCO’s SUGAM portal has had a dedicated risk classification provision since November 2025, with the equivalent for IVDs added in February 2026. Classification decides which form you file, who reviews it, and how deep the scrutiny goes. 

Settle this before anything else. A classification dispute in the middle of an application can reset your timeline.

Which Licence Do You Need?

The route depends on whether you manufacture or import.

If you manufacture in India:

  • Class A and B devices: Form MD-3 (application) and MD-5 (licence). The State Licensing Authority handles these.
  • Class C and D devices: Form MD-7 (application) and MD-9 (licence), handled by the Central Licensing Authority at CDSCO. 

 

If you import:

  • Form MD-14 (application) and MD-15 (licence) apply across all four classes and are handled by the Central Licensing Authority. The applicant is usually an Indian entity holding a valid wholesale licence, acting as the authorised agent for the foreign manufacturer.
  • Other situations include loan licences, wholesale licences, and devices with no comparable product already in the Indian market, which follow a separate pathway. Drugs and cosmetics have their own registration and licensing routes under their respective rules.

Choosing the wrong form is one of the most common reasons applications stumble. A short consultation upfront can save months.

Read more: BIS CRS Certification in India 

How the Process Works

Applications are filed online through the SUGAM portal. In plain terms:

  1. Classify your product and confirm the correct pathway.
  2. Prepare your documents. Typically, this includes company details, a device or plant master file, quality system evidence, test reports, labelling, and, for imports, a free sale certificate and authorisation from the manufacturer.
  3. Create your portal account and select the correct form.
  4. Upload documents and pay the fee online.
  5. Respond to queries from the reviewing authority.
  6. Receive the licence once review is complete, and in some cases after an inspection.

Step 5 deserves your attention. A January 2026 CDSCO notice said unanswered queries on the portal can lead to automatic rejection after a 90-day response window. If your team misses an email, you may be starting over. 

Where Businesses Get Stuck

Incomplete dossiers. Missing or inconsistent documents trigger query after query, and each round adds weeks.

Wrong classification or wrong form. This often means refiling, not fixing.

Weak quality systems. Manufacturers need a working quality management system, not just paperwork written the week before filing.

Ignoring queries. Slow replies stall the file, and silence can end it.

Treating approval as the finish line. After a licence is granted you still have obligations, including record keeping, labelling compliance, reporting, and changes to approved details through the portal.

How UMSPCS Supports You

We keep our approach practical.

  • Assessment first. We review your product, class, and readiness before recommending a route.
  • Dossier preparation. We help you build complete, consistent documentation so fewer queries come back.
  • Quality system support. We help set up and align the systems regulators expect to see.
  • Portal filing and follow-up. We handle submission, track the file, and draft clear query responses on time.
  • Inspection readiness. Where inspections apply, we prepare your team in advance.
  • After-approval guidance. We help you manage renewals, amendments, and ongoing compliance.

Our aim is to make the process predictable, so you know what’s coming at each stage.

Final Thoughts

A CDSCO licence is a gateway to the Indian market, and the businesses that handle it well start early, classify correctly, and keep their paperwork honest. If you’re planning to manufacture or import in India, UMSPCS would be glad to review where you stand and map the shortest sensible route to approval.

Frequently Asked Questions

  1. Is a CDSCO licence mandatory for every medical device in India?
    In most cases, yes. Regulated devices need either a manufacturing or import licence, and a narrow set of exceptions exists. We can confirm whether your product is covered.
  2. How do I know my device’s risk class?
    Classification depends on the device’s intended use and risk level. CDSCO publishes classification lists and a portal provision for classification queries. UMSPCS can help you reach and document the right classification.
  3. Who issues the licence, CDSCO or the state?
    It depends. Class A and B manufacturing licences come from the State Licensing Authority, while Class C and D manufacturing and all import licences come from CDSCO.
  4. How long does approval take?
    It varies with device class, document quality, and how quickly queries are answered. Complete, accurate applications move faster. We give a realistic estimate after reviewing your case.
  5. Can a foreign manufacturer apply directly?
    Usually an Indian authorised agent files on the manufacturer’s behalf. UMSPCS can guide you on this arrangement.
  6. What happens if I ignore a query on the portal?
    The application can be rejected after the response window lapses. Always track your portal and email notifications.
  7. Do I need to do anything after getting the licence?
    Yes. You’ll need to keep records, follow labelling requirements, and report approved changes through the portal. Compliance continues after approval.
  8. How can UMSPCS help me get started?
    Contact our team for an initial discussion. We’ll review your product and goals, then suggest a clear, practical path forward.

 Source: https://guestpostglobal.com/@mtcteservices/cdsco-approvals-and-licence-in-india-a-practical-guide-from-umspcs

★
★
★
★
★
Votes: 0
E-mail me when people leave their comments –

UMSPCS

You need to be a member of Global Risk Community to add comments!

Join Global Risk Community

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!

lead